SCHEMBL4019913

SCHEMBL4019913

CC(=O)Nc1cc(N)cc2cnccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 1/20 0.45
PRKCZ Q05513 1/20 0.42
PRKD2 Q9BZL6 1/20 0.42
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
DYRK1A Q13627 2/20 0.41
GALK1 P51570 1/20 0.41
ATM Q13315 1/20 0.41
CLK1 P49759 1/20 0.41
CLK2 P49760 1/20 0.41
CLK3 P49761 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
ALDH1A1 P00352 1/20 0.40
MAP4K1 Q92918 1/20 0.39
NTRK1 P04629 1/20 0.39
TRPV1 Q8NER1 6/20 0.39
MAPK10 P53779 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20072220 0.84 ALDH1A1 (0.47) CHUKPRKCZPRKD2KDM4EMAPT
SCHEMBL14503713 0.78 POLB (0.49) KDM4EMAPTALDH1A1
SCHEMBL4023574 0.77 MAPT (0.62) KDM4EMAPTGALK1ATMALDH1A1
SCHEMBL4023758 0.75 CHUK (0.44) CHUKKDM4EMAPTDYRK1ACLK1
SCHEMBL4021056 0.73 EP300 (0.51) CHUKKDM4EMAPTALDH1A1MAPK10
SCHEMBL9426430 0.73 KDM4E (0.50) CHUKKDM4EMAPTALDH1A1
SCHEMBL14357917 0.73 HDAC1 (0.46) CHUKKDM4EMAPTALDH1A1
SCHEMBL4026288 0.72 IMPDH2 (0.49) CHUKKDM4EMAPTGALK1ATM
SCHEMBL25899546 0.72 CHUK (0.43) CHUKKDM4EALDH1A1MAP4K1MAPK10
Hydrochloric Acid SCHEMBL5749683 0.71 HDAC1 (0.45) CHUKKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478363-B1 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ABBOTT LAB (US) 2009-01-14 EP claimed
EP-1478363-B1 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ABBOTT LAB (US) 2009-01-14 EP disclosed